Compound ID | 765
Class: Mutilin-quinolone hybrid
| Spectrum of activity: | Gram-negative |
| Details of activity: | Inhibits protein synthesis and bacterial Type II topoisomerases. Active against MRSA. Spontaneous mutants were identified which showed a mutation in rplV gene which encodes the L22 ribosomal protein. |
| Institute where first reported: | Kyorin Pharamaceutical Co., Ltd., Japan |
| Year first mentioned: | 2008 |
| Highest developmental phase: | Preclinical |
| Development status: | Inactive |